Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMTW.L Regulatory News (MTW)

  • There is currently no data for MTW

Rule 2.9 Announcement

10 Jul 2024 15:57

RNS Number : 9249V
Mattioli Woods PLC
10 July 2024
 

Not for release, publication or distribution, in whole or in part, DIRECTLY OR INDIRECTLY, in, INTO or FROM any jurisdiction where to do so would constitute a violation of the relevant laws of such jurisdiction

for immediate release

10 July 2024

Mattioli Woods PLC (the "Company")

Rule 2.9 Announcement

In accordance with Rule 2.9(c) of the City Code on Takeovers and Mergers (the "Takeover Code"), the Company confirms that, as at the date and time of this announcement, it had in issue 52,038,313 ordinary shares of £0.01 (one penny) each with ISIN number GB00B0MT3Y97.

The Company holds no shares in treasury.

The total number of shares attracting voting rights in the Company is therefore 52,038,313. The above figure may be used by shareholders to determine the percentage of issued share capital they hold in the Company and if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Enquiries:

Mattioli Woods plc

Ravi Tara, Chief Financial Officer

 

+44 (0) 116 240 8700

Disclosure requirements of the Code

Under Rule 8.3(a) of the Takeover Code, any person who is interested in 1 per cent. or more of any class of relevant securities of an offeree company or of any securities exchange offeror (being any offeror other than an offeror in respect of which it has been announced that its offer is, or is likely to be, solely in cash) must make an Opening Position Disclosure following the commencement of the offer period and, if later, following the announcement in which any securities exchange offeror is first identified. An Opening Position Disclosure must contain details of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company; and (ii) any securities exchange offeror(s). An Opening Position Disclosure by a person to whom Rule 8.3(a) applies must be made by no later than 3.30 p.m. (London time) on the 10th business day following the commencement of the offer period and, if appropriate, by no later than 3.30 p.m. (London time) on the 10th business day following the announcement in which any securities exchange offeror is first identified. Relevant persons who deal in the relevant securities of the offeree company or of a securities exchange offeror prior to the deadline for making an Opening Position Disclosure must instead make a Dealing Disclosure.

Under Rule 8.3(b) of the Takeover Code, any person who is, or becomes, interested in 1 per cent. or more of any class of relevant securities of the offeree company or of any securities exchange offeror must make a Dealing Disclosure if the person deals in any relevant securities of the offeree company or of any securities exchange offeror. A Dealing Disclosure must contain details of the dealing concerned and of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company; and (ii) any securities exchange offeror(s), save to the extent that these details have previously been disclosed under Rule 8. A Dealing Disclosure by a person to whom Rule 8.3(b) applies must be made by no later than 3.30 p.m. (London time) on the business day following the date of the relevant dealing.

If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire or control an interest in relevant securities of an offeree company or a securities exchange offeror, they will be deemed to be a single person for the purpose of Rule 8.3.

Opening Position Disclosures must also be made by the offeree company and by any offeror and Dealing Disclosures must also be made by the offeree company, by any offeror and by any persons acting in concert with any of them (see Rules 8.1, 8.2 and 8.4).

Details of the offeree and offeror companies in respect of whose relevant securities Opening Position Disclosures and Dealing Disclosures must be made can be found in the Disclosure Table on the Takeover Panel's website at www.thetakeoverpanel.org.uk, including details of the number of relevant securities in issue, when the offer period commenced and when any offeror was first identified. You should contact the Panel's Market Surveillance Unit on +44 (0)20 7638 0129 if you are in any doubt as to whether you are required to make an Opening Position Disclosure or a Dealing Disclosure.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RTTEALXEFSKLEFA
Date   Source Headline
1st Apr 202211:00 amRNSTotal Voting Rights
31st Mar 20227:00 amRNSDirector/PDMR Shareholding
17th Mar 20225:20 pmRNSHolding(s) in Company
15th Mar 20227:00 amRNSAppointment of Non-Executive Chairman
4th Mar 20224:00 pmRNSDirector/PDMR Shareholding
1st Mar 202211:00 amRNSTotal Voting Rights
15th Feb 20224:40 pmRNSHolding(s) in Company
11th Feb 20225:30 pmRNSDirector/PDMR Shareholding
10th Feb 20226:25 pmRNSHolding(s) in Company
9th Feb 20225:00 pmRNSDirector/PDMR Shareholding
8th Feb 20227:00 amRNSInterim Results
1st Feb 20223:02 pmRNSTotal Voting Rights
21st Jan 20227:00 amRNSUpdate to Appointment of Non-Executive Chairman
7th Jan 20225:41 pmRNSDirector/PDMR Shareholding
7th Jan 20223:59 pmRNSBlock listing Interim Review
6th Jan 20227:00 amRNSTrading Update and Notice of Interim Results
5th Jan 20228:40 amRNSTotal Voting Rights
30th Dec 20215:30 pmRNSDirector/PDMR Shareholding
30th Dec 20214:45 pmRNSAdditional Block Listing
24th Dec 20217:00 amRNSDirector/PDMR Shareholding
17th Dec 20217:00 amRNSTrading Update
13th Dec 20213:56 pmRNSHolding(s) in Company
10th Dec 20213:42 pmRNSHolding(s) in Company
7th Dec 20215:35 pmRNSHolding(s) in Company
1st Dec 202111:00 amRNSTotal Voting Rights
18th Nov 20213:15 pmRNSHolding(s) in Company
12th Nov 20213:30 pmRNSDirector/PDMR Shareholding
1st Nov 20213:00 pmRNSTotal Voting Rights
29th Oct 20213:56 pmRNSResults of Annual General Meeting
29th Oct 20217:00 amRNSAGM Statement and resolution update
12th Oct 20217:00 amRNSDirector/PDMR Shareholding
1st Oct 20211:18 pmRNSTotal Voting Rights
1st Oct 20217:30 amRNSAppointment of Chairman
1st Oct 20217:00 amRNSPosting of Annual Report and Notice of AGM
22nd Sep 20219:45 amRNSHolding(s) in Company
21st Sep 20217:08 amRNSFinal Results for the Year Ended 31 May 2021
3rd Sep 20217:00 amRNSUpdate on Timing of Full Year Results Announcement
1st Sep 20212:54 pmRNSTotal Voting Rights
1st Sep 20217:00 amRNSLudlow Wealth Management Acquisition Update
27th Aug 20217:00 amRNSAcquisition of Richings Financial Management Ltd
13th Aug 20212:45 pmRNSAmendment to Notice of Final Results
2nd Aug 20214:00 pmRNSTotal Voting Rights
9th Jul 202112:30 pmRNSHolding(s) in Company
8th Jul 20215:10 pmRNSHolding(s) in Company
8th Jul 20217:01 amRNSHolding(s) in Company
8th Jul 20217:00 amRNSDirector/PDMR Shareholding
8th Jul 20217:00 amRNSHolding(s) in Company
7th Jul 20212:45 pmRNSHolding(s) in Company
7th Jul 20211:00 pmRNSHolding(s) in Company
7th Jul 20219:00 amRNSBlock Listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.